207 related articles for article (PubMed ID: 25960238)
21. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2.
Zhong H; Yang J; Zhang B; Wang X; Pei L; Zhang L; Lin Z; Wang Y; Wang C
Cancer Biomark; 2018; 22(4):787-797. PubMed ID: 29945347
[TBL] [Abstract][Full Text] [Related]
22. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
Cui Z; Zheng X; Kong D
World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
24. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
Lin R; Shen W; Zhi Y; Zhou Z
Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
[TBL] [Abstract][Full Text] [Related]
28. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
29. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression.
Tchernitsa O; Kasajima A; Schäfer R; Kuban RJ; Ungethüm U; Györffy B; Neumann U; Simon E; Weichert W; Ebert MP; Röcken C
J Pathol; 2010 Nov; 222(3):310-9. PubMed ID: 20726036
[TBL] [Abstract][Full Text] [Related]
30. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2.
Zhang L; Liu X; Jin H; Guo X; Xia L; Chen Z; Bai M; Liu J; Shang X; Wu K; Pan Y; Fan D
Cancer Lett; 2013 May; 332(1):94-101. PubMed ID: 23348698
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
Wang LP; Ma XQ; Cai JC
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3269-73. PubMed ID: 23328512
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
33. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
Ma G; Dai W; Sang A; Yang X; Gao C
Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic significance of miR-10b expression in gastric carcinoma.
Wang YY; Ye ZY; Zhao ZS; Li L; Wang YX; Tao HQ; Wang HJ; He XJ
Hum Pathol; 2013 Jul; 44(7):1278-85. PubMed ID: 23351547
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas.
Chen L; Jiang M; Yuan W; Tang H
Acta Gastroenterol Belg; 2012 Mar; 75(1):22-7. PubMed ID: 22567743
[TBL] [Abstract][Full Text] [Related]
39. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
Xu XD; He XJ; Tao HQ; Zhang W; Wang YY; Ye ZY; Zhao ZS
J Surg Oncol; 2013 Sep; 108(3):197-202. PubMed ID: 23832550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]